← Evidence map

ArticleSignal transduction and targeted therapy2022

Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression.

Shuai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35304437